FindTrial
Sign In

Two way risk screening of type 2 diabetes mellitus and periodontitis and the effect of periodontal therapy on blood glucose control-two way risk screening section

Two way risk screening of type 2 diabetes mellitus and periodontitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052328
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Two way risk screening of type 2 diabetes mellitus and periodontitis

Interventions

Group Type 2 diabetes in community:N/A
Group Patients with periodontal disease:N/A

Sponsors

Shanghai Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 18 years old; gender is not limited; meet the diagnostic criteria for type 2 diabetes or periodontitis; voluntarily participate in clinical research, and can sign or provide authorized informed consent.

Exclusion criteria

Exclusion criteria: Those who have taken antibiotics or non-steroidal anti-inflammatory drugs in the past 3 months; those who have serious systemic diseases or complications such as blood disease, liver damage, and kidney disease, and those who suffer from systemic inflammatory diseases; Those who cannot take the questionnaire for other reasons such as barriers and inability to communicate in language; foreigners; pregnant women.

Design outcomes

Primary

MeasureTime frame
fasting blood sugar;Glycated hemoglobin;—

Secondary

MeasureTime frame
Saliva biomarkers;orthopantomogram;—

Countries

China

Contacts

Public ContactWang Yan

Shanghai Stomatological Hospital

serene2000@163.com+86 13585665561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026